Long-Term Safety of Renzapride in Women With Constipation-Predominant Irritable Bowel Syndrome (IBS-C)

Clinical trial NCT00607971 · TERMINATED

Trial details

NCT number: NCT00607971
Sponsor: Alizyme
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Constipation-Predominant Irritable Bowel Syndrome

Start date: 2006-04-01
Primary completion: 2008-06-01
Enrollment: 939

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.